Opinion

Video

Guiding Treatment Decisions: The Role of Remission Data and Head-to-Head Comparisons

Panelists discuss how head-to-head clinical trial data shape their treatment decisions, the significance of consistent remission rates across different patient populations, and the frequency with which remission data influence their choices to switch therapies.

Video content above is prompted by the following:

  • How do head-to-head data affect your treatment decisions?
  • What does consistency of remission across patient types mean to you?

How often do you rely on remission data when considering switching therapies?

Related Videos
Zoi Papalamprakopoulou, MD | Credit: Papalamprakopoulou on LinkedIn
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Wei Zhang, MD PhD | Credit: Mass Gen
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
The APAC Recap: Dyslipidemia at CAPP Live 2024 with Viet Le, DMSc, PA-C | Image Credit: APAC
4 experts are featured in this series.
© 2024 MJH Life Sciences

All rights reserved.